随着新冠肺炎的治疗方案及疫苗研发进程不断推进,沃伦·巴菲特的伯克希尔-哈撒韦公司(Berkshire Hathaway Inc.)正在加码押注大型药企。
伯克希尔于11月16日提交给监管机构的备案文件显示,该公司在第三季度新入股了默沙东(Merck & Co.)和辉瑞(Pfizer Inc.),还增加了艾伯维(AbbVie Inc.)以及百时美施贵宝(Bristol-Myers Squibb Co.)的持股比例,以上几家公司均为制药企业。与此同时,伯克希尔继续减持富国银行(Wells Fargo & Co.)和摩根大通(JPMorgan Chase & Co.)等金融领域股份,后者的削减比例已经累计达96%。
巴菲特的选择是对的。在伯克希尔入股药企后几个月不到的时间里,辉瑞与其合作伙伴BioNTech SE便宣布称其联合研发的最新疫苗能够有效保护大部分人免受新冠病毒感染。此消息一出,瑞辉股价当即应声大涨。另外,默沙东也在持续推进更多新冠肺炎的治疗方案。
目前美国官方表示,一旦疫苗获准批量生产,政府人员将不遗余力地立即进行派发工作,而伯克希尔此番增持,也顺势谋得了更多主动权。据监管备案文件,截至本月末,伯克希尔分别持有艾伯维、百时美施贵宝和默沙东各18亿美元的股份,同时持有辉瑞1.36亿美元的股份。当然,文件亦对一些机密信息进行了保留。
回顾巴菲特在整个疫情期间的投资行为,可以发现他一向比较谨慎。5月伯克希尔的现金储备量达到了创纪录的1450亿美元,然而巴菲特本人却说:“将来的情况还可能会更糟,资金回撤行动还会继续下去。”后来,巴菲特把资金重新部署到了日本五家大型贸易公司,又出其不意地进军美国天然气能源领域,还回购了一部分伯克希尔自己的股票,这才把账面上的现金花出去了一些。反观巴菲特的老朋友、伯克希尔的前董事会成员比尔·盖茨,则在同一时期致力于基金会的捐款事宜,以此帮助推进疫苗研发工作。
众所周知,巴菲特在疫情早期大量抛售了航空股和金融股,在后几个季度,减持银行股也一直都是巴菲特的策略主线,除了文首所提到的富国银行和摩根大通,被伯克希尔逐渐抛弃的还有PNC金融服务集团(PNC Financial Services Group)和M&T银行(M&T Bank Corp)。截至9月底,富国银行被伯克希尔买入的股份下降到了1.27亿美元,而它曾经是伯克希尔最大的一笔投资之一,由此足见这其中的变化之大。
最后值得注意的是,伯克希尔在第三季度还买入了T-Mobile US Inc.的股份,金额达2.76亿美元。(财富中文网)
编译:陈怡轩
随着新冠肺炎的治疗方案及疫苗研发进程不断推进,沃伦·巴菲特的伯克希尔-哈撒韦公司(Berkshire Hathaway Inc.)正在加码押注大型药企。
伯克希尔于11月16日提交给监管机构的备案文件显示,该公司在第三季度新入股了默沙东(Merck & Co.)和辉瑞(Pfizer Inc.),还增加了艾伯维(AbbVie Inc.)以及百时美施贵宝(Bristol-Myers Squibb Co.)的持股比例,以上几家公司均为制药企业。与此同时,伯克希尔继续减持富国银行(Wells Fargo & Co.)和摩根大通(JPMorgan Chase & Co.)等金融领域股份,后者的削减比例已经累计达96%。
巴菲特的选择是对的。在伯克希尔入股药企后几个月不到的时间里,辉瑞与其合作伙伴BioNTech SE便宣布称其联合研发的最新疫苗能够有效保护大部分人免受新冠病毒感染。此消息一出,瑞辉股价当即应声大涨。另外,默沙东也在持续推进更多新冠肺炎的治疗方案。
目前美国官方表示,一旦疫苗获准批量生产,政府人员将不遗余力地立即进行派发工作,而伯克希尔此番增持,也顺势谋得了更多主动权。据监管备案文件,截至本月末,伯克希尔分别持有艾伯维、百时美施贵宝和默沙东各18亿美元的股份,同时持有辉瑞1.36亿美元的股份。当然,文件亦对一些机密信息进行了保留。
回顾巴菲特在整个疫情期间的投资行为,可以发现他一向比较谨慎。5月伯克希尔的现金储备量达到了创纪录的1450亿美元,然而巴菲特本人却说:“将来的情况还可能会更糟,资金回撤行动还会继续下去。”后来,巴菲特把资金重新部署到了日本五家大型贸易公司,又出其不意地进军美国天然气能源领域,还回购了一部分伯克希尔自己的股票,这才把账面上的现金花出去了一些。反观巴菲特的老朋友、伯克希尔的前董事会成员比尔·盖茨,则在同一时期致力于基金会的捐款事宜,以此帮助推进疫苗研发工作。
众所周知,巴菲特在疫情早期大量抛售了航空股和金融股,在后几个季度,减持银行股也一直都是巴菲特的策略主线,除了文首所提到的富国银行和摩根大通,被伯克希尔逐渐抛弃的还有PNC金融服务集团(PNC Financial Services Group)和M&T银行(M&T Bank Corp)。截至9月底,富国银行被伯克希尔买入的股份下降到了1.27亿美元,而它曾经是伯克希尔最大的一笔投资之一,由此足见这其中的变化之大。
最后值得注意的是,伯克希尔在第三季度还买入了T-Mobile US Inc.的股份,金额达2.76亿美元。(财富中文网)
编译:陈怡轩
Warren Buffett’s Berkshire Hathaway Inc. is betting on big pharma as the industry’s fortunes swing on the development of a Covid-19 vaccine and therapeutics.
Berkshire disclosed new investments in Merck & Co. and Pfizer Inc. during the third quarter, while also adding bets on AbbVie Inc. and Bristol-Myers Squibb Co., according to a regulatory filing Monday. Meanwhile, Buffett’s conglomerate continued to cut stakes in financial companies, including Wells Fargo & Co. and JPMorgan Chase & Co.
Berkshire started snapping up the health stocks just months ahead of a disclosure from Pfizer and BioNTech SE that their vaccine protects most people from Covid-19, news that sent Pfizer stock soaring. Merck has also been pushing ahead with therapies for the virus.
The bets give Berkshire more exposure to pharmaceutical companies as officials prepare to ramp up efforts to distribute a Covid-19 vaccine whenever one is approved. Buffett’s company had stakes valued at more than $1.8 billion each in AbbVie, Bristol-Myers Squibb and Merck at the end of the quarter, and about $136 million in Pfizer. Berkshire omitted some confidential information with its routine regulatory filing.
Buffett, 90, has been cautious during the pandemic, saying in May that his then-record cash pile wasn’t that huge when considering the worst-case possibilities. He’s since deployed cash in Japan and into natural-gas assets, and has bought back Berkshire’s own stock. His friend Bill Gates, a former Berkshire board member, has been donating through his foundation to help fund vaccine efforts.
Buffett, Berkshire’s chairman and chief executive officer, dumped airline stocks and sold financials earlier in the crisis. His company continued to pare bank holdings in the third quarter, trimming Berkshire’s Wells Fargo stake and slashing its JPMorgan investment by 96%. Berkshire also cut stakes in PNC Financial Services Group Inc. and M&T Bank Corp. Berkshire has been chipping away at its Wells Fargo stake in recent months after more than three decades holding onto that bet. It held about 127 million shares at the end of September, a marked shift for an investment that once ranked as Berkshire’s biggest.
Berkshire also took a stake in T-Mobile US Inc. during the third quarter, a holding valued at $276 million.